Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

X

William Newton

22 Sep 2021

Analysis

Merck and Ridgeback’s molnupiravir rollout difficult to map in uncertain Covid-19 landscape

22 Sep 2021

20 Sep 2021

News

Oral molnupiravir has at least 350 patients left to recruit in Phase III Covid-19 trial

20 Sep 2021

27 Aug 2021

Analysis

Retrotope eyes $100m raise for neurodegenerative disease platform

27 Aug 2021

09 Feb 2021

Comment

Ampio open to CRO offers to run Phase I long hauler Covid study scheduled to start 1Q, CEO says

09 Feb 2021

05 Feb 2021

Comment

Quercis enlists Clinipace for Phase III trial in pancreatic cancer-related venous thromboembolism; in $40m-$60m fundraise, CEO says

05 Feb 2021

05 Feb 2021

Comment

Covaxx commissions CRO PPD for Phase II/III Covid-19 vaccine trial in Brazil, CEO says

05 Feb 2021

04 Feb 2021

Comment

BirchBioMed to seek a CRO in about two months for topical scarring study, CEO says

04 Feb 2021

25 Jan 2021

Comment

Adastra eyes CRO pitches for Phase II trial of anticancer candidate; initiates $45m Series B fundraising, exec says

25 Jan 2021

22 Jan 2021

Comment

Orphazyme’s arimoclomol expected to be used with Zavesca after likely FDA approval in Niemann-Pick disease type C

22 Jan 2021

29 Dec 2020

Comment

Oblato open to CRO pitches for paediatric cancer candidate OKN-007, exec says

29 Dec 2020